Experts, Avinnash Gorakssakar, founder director of Moneyinvestments.in, and Gaurang Shah, assistant vice president of Geojit BNP Paribas Financial Services, discuss the stock market performance. While Mr Shah prefers Cipla, Glenmark Pharma, Cadila stocks in the pharma space, Mr Gorakssakar is overweight on Glenmark Pharma and expects re-rating of Cipla. They also discuss realty and aviation stocks.